Sands Capital Ventures’s Tarsus Pharmaceuticals TARS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.89M | Hold |
170,000
| – | – | 1.36% | 12 |
|
|
2025
Q1 | $8.73M | Hold |
170,000
| – | – | 2.14% | 10 |
|
|
2024
Q4 | $9.41M | Hold |
170,000
| – | – | 2.05% | 10 |
|
|
2024
Q3 | $5.59M | Hold |
170,000
| – | – | 1.57% | 10 |
|
|
2024
Q2 | $4.62M | Hold |
170,000
| – | – | 1.55% | 9 |
|
|
2024
Q1 | $6.18M | Sell |
170,000
-90,000
| -35% | -$3.27M | 1.49% | 9 |
|
|
2023
Q4 | $5.27M | Hold |
260,000
| – | – | 1.46% | 10 |
|
|
2023
Q3 | $4.62M | Hold |
260,000
| – | – | 1.37% | 12 |
|
|
2023
Q2 | $4.7M | Hold |
260,000
| – | – | 1.39% | 10 |
|
|
2023
Q1 | $3.27M | Hold |
260,000
| – | – | 0.81% | 12 |
|
|
2022
Q4 | $3.81M | Hold |
260,000
| – | – | 1.04% | 13 |
|
|
2022
Q3 | $4.45M | Hold |
260,000
| – | – | 1.29% | 12 |
|
|
2022
Q2 | $3.8M | Hold |
260,000
| – | – | 1.04% | 13 |
|
|
2022
Q1 | $4.37M | Hold |
260,000
| – | – | 0.91% | 14 |
|
|
2021
Q4 | $5.85M | Hold |
260,000
| – | – | 0.87% | 14 |
|
|
2021
Q3 | $5.6M | Buy |
+260,000
| New | +$5.6M | 0.84% | 11 |
|